Lakefront Biotherapeutics (LKFT) Change in Inventory (2016 - 2020)
Lakefront Biotherapeutics (LKFT) posted quarterly Change in Inventory of $124037.0 for Q2 2020, up 2280.0% year-on-year from $5211.6 in Q3 2019, and up 275.81% on a QoQ basis from -$70553.2 in Q1 2020.
Lakefront Biotherapeutics (LKFT) Change in Inventory (2016 - 2020) Analysis & Trends
Lakefront Biotherapeutics (LKFT) has reported Change in Inventory for 5 consecutive years, with $124037.0 the latest figure, recorded in Q2 2020.
- Quarterly Change in Inventory rose 2280.0% year-over-year to $124037.0 in Q2 2020, while the trailing twelve-month figure through Jun 2020 was $34138.6 (up 235.17% YoY) and the FY2025 annual result came in at $32.8 million, up 25.23% from the prior year.
- Change in Inventory improved to $124037.0 in Q2 2020 per LKFT's latest filing, from -$70553.2 in the prior quarter.
- Over the last five years, Change in Inventory for LKFT reached as high as $26.0 million in Q3 2017 and fell as low as -$25.9 million in Q2 2017.
- A 5-year average of -$476.96 and a median of -$3982.8 in 2018 frame the typical range for Change in Inventory.
- Annual changes were most pronounced in 2017 — Change in Inventory tumbled 69238.46% — and 2020, when it soared 2280.0%.
- Year by year, Change in Inventory stood at $37523.5 in 2016, then tumbled by 192.31% to -$34637.0 in 2017, then surged by 93.43% to -$2275.9 in 2018, then sank by 1050.0% to -$26172.9 in 2019, then soared by 573.91% to $124037.0 in 2020.
- According to Business Quant data, Change in Inventory over the past three periods registered $124037.0, -$70553.2, and -$26172.9 for Q2 2020, Q1 2020, and Q4 2019 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 71.84 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 97.70 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -26.60 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Lakefront Biotherapeutics | 1.86 Bn | -1.54 Bn | 1.91 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | 124,037.02 |
| Jun 30, 2020 | 124,037.02 |
| Mar 31, 2020 | -70,553.16 |
| Mar 31, 2020 | -70,553.16 |
| Dec 31, 2019 | -26,172.95 |
| Dec 31, 2019 | -26,172.95 |
| Sep 30, 2019 | 6,827.73 |
| Sep 30, 2019 | 6,827.73 |
| Jun 30, 2019 | -5,689.77 |
| Jun 30, 2019 | -5,689.77 |
| Mar 31, 2019 | 2,275.91 |
| Mar 31, 2019 | 2,275.91 |
| Dec 31, 2018 | -2,275.91 |
| Dec 31, 2018 | -2,275.91 |
| Sep 30, 2018 | 15,875.31 |
| Sep 30, 2018 | 15,875.31 |
| Jun 30, 2018 | 2,886.42 |
| Jun 30, 2018 | 2,886.42 |
| Mar 31, 2018 | -20,204.94 |
| Mar 31, 2018 | -20,204.94 |